SCHEDULE OF PERFORMANCE AND MAKING KEY DECISIONS REGARDING RESOURCE ALLOCATION (Details) |
3 Months Ended | 7 Months Ended |
|---|---|---|
|
Sep. 30, 2025
USD ($)
|
Sep. 30, 2025
USD ($)
|
|
| Segment Reporting [Abstract] | ||
| Cash and marketable securities held in Trust Account | $ 245,365,396 | $ 245,365,396 |
| Cash | 846,736 | 846,736 |
| Prepaid Expense and Prepaid Insurance | 185,223 | 185,223 |
| Formation, general and administrative expenses | 273,302 | 616,475 |
| Income earned on marketable securities held in Trust Account | $ 2,569,088 | $ 3,865,396 |
| X | ||||||||||
- Definition The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate within one year of the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|